A PCA approach to population analysis: with application to a Phase II depression trial
暂无分享,去创建一个
[1] Thierry d'Amato,et al. Validity of the depressive dimension extracted from principal component analysis of the PANSS in drug-free patients with schizophrenia , 2002, Schizophrenia Research.
[2] Donald A. Jackson,et al. How many principal components? stopping rules for determining the number of non-trivial axes revisited , 2005, Comput. Stat. Data Anal..
[3] W. Berry. LARGE SCALE SPARSE SINGULAR VALUE COMPUTATIONSMICHAEL , 1992 .
[4] An Vermeulen,et al. Structural Models Describing Placebo Treatment Effects in Schizophrenia and Other Neuropsychiatric Disorders , 2011, Clinical pharmacokinetics.
[5] D. Harville. Maximum Likelihood Approaches to Variance Component Estimation and to Related Problems , 1977 .
[6] Erik van Zwet,et al. Heterogeneity in patient response in depression: The relevance of functional data analysis , 2008 .
[7] Hojjat Adeli,et al. Principal Component Analysis-Enhanced Cosine Radial Basis Function Neural Network for Robust Epilepsy and Seizure Detection , 2008, IEEE Transactions on Biomedical Engineering.
[8] Giuseppe De Nicolao,et al. Bayesian Population Modeling of Phase I Dose Escalation Studies: Gaussian Process Versus Parametric Approaches , 2011, IEEE Transactions on Biomedical Engineering.
[9] R. Gomeni,et al. Bayesian modelling and ROC analysis to predict placebo responders using clinical score measured in the initial weeks of treatment in depression trials. , 2007, British journal of clinical pharmacology.
[10] R. Cattell. The Scree Test For The Number Of Factors. , 1966, Multivariate behavioral research.
[11] D. Reich,et al. Principal components analysis corrects for stratification in genome-wide association studies , 2006, Nature Genetics.
[12] Petre Stoica,et al. Decentralized Control , 2018, The Control Systems Handbook.
[13] R. Gomeni,et al. Modelling placebo response in depression trials using a longitudinal model with informative dropout. , 2009, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[14] J. Edward Jackson,et al. A User's Guide to Principal Components. , 1991 .
[15] Michael Krams,et al. Evaluation of structural models to describe the effect of placebo upon the time course of major depressive disorder , 2009, Journal of Pharmacokinetics and Pharmacodynamics.
[16] M. Hamilton. A RATING SCALE FOR DEPRESSION , 1960, Journal of neurology, neurosurgery, and psychiatry.
[17] C. L. Mallows. Some comments on C_p , 1973 .
[18] Italo Poggesi,et al. Model-based approaches to increase efficiency of drug development in schizophrenia: a can't miss opportunity , 2009, Expert opinion on drug discovery.
[19] C. Mallows. Some Comments on Cp , 2000, Technometrics.
[20] Geert Molenberghs,et al. Analyzing incomplete longitudinal clinical trial data. , 2004, Biostatistics.
[21] Michael J. Black,et al. Robust Principal Component Analysis for Computer Vision , 2001, ICCV.
[22] J. E. Jackson. A User's Guide to Principal Components , 1991 .
[23] Meindert Danhof,et al. Evaluation of treatment response in depression studies using a Bayesian parametric cure rate model. , 2008, Journal of psychiatric research.
[24] D R Mould,et al. Using Disease Progression Models as a Tool to Detect Drug Effect , 2007, Clinical pharmacology and therapeutics.
[25] I. Jolliffe. Principal Component Analysis , 2002 .
[26] H. Abdi,et al. Principal component analysis , 2010 .
[27] Alkes L. Price,et al. New approaches to population stratification in genome-wide association studies , 2010, Nature Reviews Genetics.
[28] C. Mallows. More comments on C p , 1995 .
[29] J. L. Steimer,et al. Variability in drug therapy : description, estimation, and control : a Sandoz workshop , 1985 .
[30] R Core Team,et al. R: A language and environment for statistical computing. , 2014 .
[31] J. Edward Jackson,et al. A User's Guide to Principal Components: Jackson/User's Guide to Principal Components , 2004 .
[32] Joshua M. Stuart,et al. MICROARRAY EXPERIMENTS : APPLICATION TO SPORULATION TIME SERIES , 1999 .
[33] Mark E. Sale,et al. A Joint Model for Nonlinear Longitudinal Data with Informative Dropout , 2003, Journal of Pharmacokinetics and Pharmacodynamics.